Document is current
Any future updates will be listed below
-
Authors
Odzer, Nicole
Chehayeb, Rachel Jaber
Schellhorn, Sarah E.
Lustberg, Maryam
Gross, Cary P.
Lee, Do
Foldi, Julia https://orcid.org/0000-0002-7504-867X
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 4 June 2025
First Online: 11 June 2025
Declarations
:
: The study was approved by the Institutional Review Boards (IRB) at Yale University (HIC #). Given the minimal risk of the study, the IRBs determined that the study was exempt from having to obtain informed consent from patients.
: Dr. Gross has received research funding from the NCCN Foundation (with funds provided to NCCN by Astra-Zeneca) and Genentech, as well as funding from Johnson and Johnson to help devise and implement new approaches to sharing clinical trial data. Dr. Foldi has received honoraria from OncLive and Research To Practice, Inc., consulting fees from BioTheranostics, Inc, a Hologic Company and research funding (to institution) from Conquer Cancer and the Pennsylvania Breast Cancer Coalition, outside of the submitted work. The remaining authors declare no competing interests.
